Journal of Experimental & Clinical Cancer Research (JECCR) is the official scientific journal of the "Regina Elena" National Cancer Institute since 1986 which publishes manuscripts regarding significant advances in basic cancer research and offers a translational bridge from the laboratory to the clinic.

The most important aims are to open new roads for the understanding, prevention, diagnosis and treatment of cancer and to share the scientific results with the international scientific community.

JECCR has led its editorial activity by maintaining its partnership with the publisher BioMed Central - Springer Nature in London.

Thanks to its “open access” version, JECCR improved its performance in terms of rapid publication of the articles, better widespread all scientific results and higher visibility in the scientific community confirming its position in the 1st quartile among International Oncology Journals

In 2021 JECCR has launched a new Special Issue regarding the latest highlights on drugging cancer vulnerabilities toward innovative clinical trial.

The main accomplishments achieved by JECCR in 2021 are:

• Impact Factor 11.161;
• 2,059,766 downloads;
• 2758 submissions;
• 342 published papers;

Most of submitted and published articles in the last years comes from International Oncology Institutes and Universities worldwide.

The “Journal of Experimental & Clinical Cancer Research” has reinforced its visibility in the international scientific community sharing the latest articles and collections by Social Media. JECCR online website: https://jeccr.biomedcentral.com/